TearLab Corporation (TEAR)
(Delayed Data from OTC)
$0.06 USD
0.00 (0.00%)
Updated Jul 9, 2020 09:35 AM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
TearLab Corporation [TEAR]
Reports for Purchase
Showing records 121 - 140 ( 165 total )
Company: TearLab Corporation
Industry: Medical - Instruments
Company: TearLab Corporation
Industry: Medical - Instruments
Healthcare - 3Q 2013: Quarterly Medical Technology Trading & Acquisition Update
Provider: Roth Capital Partners, Inc.
Company: TearLab Corporation
Industry: Medical - Instruments
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: TearLab Corporation
Industry: Medical - Instruments
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: TearLab Corporation
Industry: Medical - Instruments
Still in the second inning of adoption, orders strong, backlog persists, raising PT to $17.00
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: TearLab Corporation
Industry: Medical - Instruments
2Q Reflects Growing Adoption; Panel Discussion Confirms Clinical Value
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: TearLab Corporation
Industry: Medical - Instruments
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: TearLab Corporation
Industry: Medical - Instruments
Nothing Dry About This Story-Raising PT on Prelim. 2Q, Accelerated Demand
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: TearLab Corporation
Industry: Medical - Instruments
Healthcare - 2Q 2013: Quarterly Medical Technology Trading & Acquisition Update
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: TearLab Corporation
Industry: Medical - Instruments
Company: TearLab Corporation
Industry: Medical - Instruments
Company: TearLab Corporation
Industry: Medical - Instruments
Channel checks suggest commercial account growth surpassing Q1, raising target to $15
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: TearLab Corporation
Industry: Medical - Instruments
Eye Watering Orders - Suggest Revenue Momentum Building; Raising Target
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: TearLab Corporation
Industry: Medical - Instruments
Customers driven to TEAR in Q1 - TearLab orders best our estimates by ~70%
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: TearLab Corporation
Industry: Medical - Instruments
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: TearLab Corporation
Industry: Medical - Instruments
1Q13 Preview: Expect Momentum/Demand to Continue; Buy
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: TearLab Corporation
Industry: Medical - Instruments
Healthcare - 1Q 2013: Quarterly Medical Technology Trading & Acquisition Update
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: TearLab Corporation
Industry: Medical - Instruments
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: TearLab Corporation
Industry: Medical - Instruments
Strong 4Q Placements & Good Momentum into 2013; Maintain Buy
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: TearLab Corporation
Industry: Medical - Instruments
Massive Q4 orders cause backlog, strong uptake continues, raising numbers and target
Provider: FELTL & COMPANY
Analyst: HAYNOR B